Identification of a Targeting Factor for Posttranslational Membrane Protein Insertion into the ER  by Stefanovic, Sandra & Hegde, Ramanujan S.
Identification of a Targeting Factor
for Posttranslational Membrane
Protein Insertion into the ER
Sandra Stefanovic1 and Ramanujan S. Hegde1,*
1Cell Biology and Metabolism Branch, National Institute of Child Health and Human Development, National Institutes of Health,
Room 101, Building 18T, 18 Library Drive, Bethesda, MD 20892, USA
*Correspondence: hegder@mail.nih.gov
DOI 10.1016/j.cell.2007.01.036SUMMARY
Hundreds of proteins are anchored in intracellu-
lar membranes by a single transmembrane do-
main (TMD) close to the C terminus. Although
these tail-anchored (TA) proteins serve numer-
ous essential roles in cells, components of their
targeting and insertion pathways have long re-
mained elusive. Here we reveal a cytosolic
TMD recognition complex (TRC) that targets
TA proteins for insertion into the ERmembrane.
The highly conserved, 40 kDa ATPase subunit
of TRC (which we termed TRC40) was identified
as Asna-1. TRC40/Asna-1 interacts posttrans-
lationally with TA proteins in a TMD-dependent
manner for delivery to a proteinaceous receptor
at the ER membrane. Subsequent release from
TRC40/Asna-1 and insertion into themembrane
depends on ATP hydrolysis. Consequently, an
ATPase-deficient mutant of TRC40/Asna-1
dominantly inhibited TA protein insertion selec-
tively without influencing other translocation
pathways. Thus, TRC40/Asna-1 represents an
integral component of a posttranslational path-
way of membrane protein insertion whose
targeting is mediated by TRC.
INTRODUCTION
A fundamental problem in biology is the insertion of pro-
teins into biological membranes. This problem is further
complicated in eukaryotic cells by an extensive array of in-
tracellular organelles that necessitates highly selective
targeting to one among many membrane systems. For
membrane protein biogenesis at the ER, the most well-
studied mechanism is a cotranslational insertion pathway
mediated by the cytosolic signal recognition particle
(SRP), the ER-localized SRP receptor (SR), and an ER pro-
tein translocon whose central channel is formed by the
Sec61 complex (Shan and Walter, 2005; Osborne et al.,C2005). These basic components are highly conserved
from bacterial to mammalian systems and are demon-
strated to play an essential role in the biosynthesis of
a wide range of membrane proteins.
Although ubiquitous, this cotranslational SRP-depen-
dent pathway is inaccessible to a large class of membrane
proteins whose only targeting information is encoded in
a single transmembrane domain (TMD) close to the C ter-
minus (Kutay et al., 1993; Wattenberg and Lithgow, 2001;
Borgese et al., 2003; High and Abell, 2004). These tail-
anchored (TA) proteins are released from the ribosome
before the TMD emerges from the ribosomal tunnel (which
shields 30–40 residues), precluding cotranslational tar-
geting and translocation. TA proteins are surprisingly
abundant in various membrane systems of the eukaryotic
cell and play critical roles in nearly all aspects of cell biol-
ogy (Borgese et al., 2003). Notable examples include the
SNAREs involved in vesicular trafficking, several compo-
nents of translocons in various organelles, components
of membrane-bound degradation machinery, structural
proteins for Golgi morphology, and numerous enzymes
whose activities are spatially restricted in the cell. Despite
this broad functional importance of TA proteins, the path-
ways by which they are targeted to or inserted into the ER
membrane remain very poorly understood.
With some exceptions (such as cytochrome b5 [Cb5]),
most ER-targeted TA proteins are thought to be inserted
via an energy-dependent process that involves at least
one proteinaceous component of the ER. Early reconstitu-
tion studies suggested convincingly that components of
the ER other than the minimal cotranslational machinery
(SR, Sec61, and translocating chain-associating mem-
brane protein [TRAM]) were necessary for insertion of
the model TA protein synaptobrevin (Kutay et al., 1995).
Since that time, a variety of studies have confirmed an
ATP requirement for several other TA proteins, provided
further support for yet unidentified membrane factors,
and characterized some of the sequence requirements
for TMD insertion (Kutay et al., 1995; Whitley et al., 1996;
Kim et al., 1997, 1999; Steel et al., 2002; Borgese
et al., 2001; Abell et al., 2003). These biochemical analy-
ses were buttressed with studies in yeast showing that
various mutants in the known co- or posttranslationalell 128, 1147–1159, March 23, 2007 ª2007 Elsevier Inc. 1147
translocation pathways are not impaired in TA protein
insertion (Steel et al., 2002; Yabal et al., 2003). While re-
cent crosslinking analyses were used to suggest interac-
tions between TA proteins and components of the SRP
and Sec61 pathways (Abell et al., 2003, 2004), the func-
tional relevance of these observations remains largely un-
certain and in contradiction to previous studies arguing
against a role for these components (e.g., Kutay et al.,
1995). Thus, the main consensus from the sum of the
available studies is that components in the cytosol and
membrane, at least one of which may be dependent on
ATP, are involved in insertion. However, the identity of
the ATP-requiring component(s), the membrane recep-
tor(s), and their mechanisms of action have long remained
elusive.
Clarification of these issues will require identification of
components in the pathway of insertion. A major obstacle
to achieving this goal has been the heterogeneity of inser-
tion assays that rely on measuring membrane binding of
TA proteins. A binding assay can contribute significant
background noise by not reliably distinguishing a physio-
logically relevant membrane-spanning orientation from
other modes of membrane association, insertion, or ag-
gregation. Hence, the small dynamic range, low through-
put, and low sensitivity of this assay have precluded signif-
icant attempts at identification of components involved in
either targeting or insertion. Recently, this obstacle was
overcome by a protease protection assay that not only
showed high sensitivity and specificity, but could be em-
ployed in combination with fractionation of the lysate
components (Brambillasca et al., 2005). This approach
greatly facilitated a detailed analysis of Cb5 insertion by
the spontaneous pathway (defined here as not requiring
any protein factors in the membrane). This study revealed
a previously unappreciated ER dependence on lipid com-
position for insertion of Cb5. Exploiting this advance in
methodology, we have now dissected the more broadly
utilized, but poorly understood, nonspontaneous TA inser-
tion pathway to identify a key cytosolic component of
a TMD recognition complex (TRC) that functions in post-
translational membrane protein targeting. Our results de-
lineate the principal steps in posttranslational membrane
protein insertion, allow us to propose a working mechanis-
tic framework for this ubiquitous and physiologically
important pathway, and explain how the TRC- and SRP-
dependent pathways operate in parallel without cross-
interference.
RESULTS AND DISCUSSION
TA Protein Insertion by an Energy-Dependent
Protein-Requiring Pathway
The requirements for transmembrane insertion of a model
TA protein were analyzed in vitro. The ER translocon com-
ponent Sec61b was chosen because it is unambiguously
inserted solely into the ER, is not trafficked elsewhere,
is definitively confirmed to fully span the membrane
(as opposed to a hairpin topology), and is highly1148 Cell 128, 1147–1159, March 23, 2007 ª2007 Elsevier Incconserved and universally expressed (Hartmann et al.,
1994; Toikkanen et al., 1996; Van den Berg et al., 2004).
Hence, Sec61b insertion almost certainly utilizes a general
and widely applicable ER-selective pathway whose com-
ponents are likely to be found in all cells, making its
analysis in heterologous in vitro systems physiologically
relevant.
Using a recently developed protease protection assay
(see Figure S1A in the Supplemental Data), an epitope-
tagged Sec61b (referred to hereafter as just Sec61b; see
Table S1 in the Supplemental Data) synthesized in a retic-
ulocyte lysate was found to insert posttranslationally into
ER-derived rough microsomes (RMs). Correct transmem-
brane orientation was verified by recovery of a protease
protected fragment (PF) representing the epitope-tagged
transmembrane segment (Figures 1A and 1B). The PF
was not observed when RMs were omitted, if detergent
was included in the protease digestion reaction, or if the
TMD was deleted from Sec61b (Figures 1A and 1B; Fig-
ures S1B and S1C). The choice of epitope tag did not in-
fluence the insertion (Figure S1C), and the PF was con-
firmed in sedimentation assays to cofractionate with
RMs (data not shown). Quantitation by phosphorimaging
(after accounting for methionine distribution) showed
better than 50% absolute insertion efficiency.
Using the generation of PF as a diagnostic marker for
correct transmembrane orientation, Sec61b insertion
was shown to occur at temperatures above 24C, was
complete within 15 min at 32C, and was stimulated signif-
icantly by an energy regenerating system (Figures 1B and
1C). Using a panel of previously characterized fraction-
ated proteoliposomes and liposomes (see Table S2), we
analyzed the membrane requirements for Sec61b inser-
tion. These experiments showed that Sec61b inserts effi-
ciently into proteoliposomes reconstituted from total ER
membrane proteins (rRM), but not liposomes (Figure 1D;
Figures S1C–S1E) or protease-digested proteoliposomes
(Figure 1E). This contrasted with Cb5, whose spontaneous
transmembrane insertion into liposomes (or protease-
digested proteoliposomes) appears to occur by a pathway
not available to Sec61b (Figures 1D and 1E, and Figures
S1D and S1E; Brambillasca et al., 2005).
Analyses in various fractionated proteoliposomes
(Figure 1F; Table S2) suggested that depletion of known
translocon components by 95% or more was without
effect on Sec61b insertion. These depletions included
the Sec61 complex, TRAM, the TRAP complex, Sec62,
Sec63, oligosaccharyl transferase, and signal peptidase
complex. Conversely, proteoliposomes containing only
the SR and Sec61 complex failed to support Sec61b inser-
tion even though they were competent for cotranslational
translocation of Prl and posttranslational insertion of Cb5
(Figure 1D). Furthermore, modification of free cysteines on
the ER membrane (which inhibits cotranslational trans-
location by modification of the SR; Andrews et al.,
1989) had no effect on Sec61b insertion (Figure 1G)
despite complete blockage of cotranslational transloca-
tion (Figure 1H). Considered together, these findings.
Figure 1. Characterization of a Posttranslational Membrane Protein Insertion Pathway
(A) Prolactin and Sec61b were synthesized in vitro for 30 min at 32C with or without ER-derived rough microsomes (RM) and analyzed by a protease
protection assay (Figure S1A) using proteinase K (PK). The precursor (pPrl) and processed (Prl) forms of Prolactin are indicated, as are the full length
(FL) and protected fragment (PF) species of Sec61b. The diffuse band just above Sec61b is hemoglobin from the reticulocyte lysate.
(B) Lanes 1–4 are immunoprecipitates (against a C-terminal epitope tag; see Figure S1A) of translocation reactions as in (A). Lanes 5–12 are Sec61b
translation products (without RMs, as in lane 3) that were posttranslationally incubated with RMs at the indicated temperatures for between 0 to
60 min before analysis by PK digestion and immunoprecipitation to recover the PF.
(C) Sec61b translated without RM was isolated by immunoaffinity chromatography (to remove free nucleotides), and the eluted products were tested
for insertion into RM in the absence or presence of an energy regenerating system. Quantification by phosphorimaging showed 3-fold increased
insertion with energy.
(D) Cotranslational translocation of Prl and posttranslational insertion of Sec61b and Cb5 were tested with the indicated membrane vesicles (see
Table S2) using a protease protection assay. This Cb5 construct (see Table S1) has a glycosylation site at the C terminus that is modified upon in-
sertion into RM (and to a small extent, in rRM). The lack of Prl processing in Sec61/SR proteoliposomes is due to the absence of signal peptidase.
(E) Time course (at 25C) of Sec61b and Cb5 insertion into rRM (solid lines) or rRM-PK (reconstituted from PK-digested ER membrane proteins).
(F) Posttranslational insertion of Sec61b was tested with the indicated membrane vesicles (see Table S2). Only the protease-digested, immunopre-
cipitated samples are shown.
(G and H) RM treated with Biotin-maleimide (to modify exposed sulfhydryls) and mock-treated RM was tested for cotranslational translocation of Prl
and posttranslational insertion of Sec61b and Cb5. In addition to protease protection, Cb5 insertion and Prl translocation can also be observed by
their glycosylation and signal cleavage, respectively.demonstrate that like synaptobrevin (Kutay et al., 1995),
insertion of Sec61b occurs by an energy-stimulated,
protein-dependent, posttranslational mechanism that
appears to be distinct from the known cotranslational or
spontaneous insertion pathways.CDetection of a Cytosolic Targeting Complex for TA
Protein Insertion
To find potential components involved in TA protein inser-
tion, we took an unbiased approach utilizing a combination
of fractionation, crosslinking, and functional insertionell 128, 1147–1159, March 23, 2007 ª2007 Elsevier Inc. 1149
Figure 2. Detection of a Targeting Factor
for Posttranslational Membrane Protein
Insertion
(A) Sec61b translated in reticulocyte lysate was
fractionated using a sucrose velocity gradient
and detected by autoradiography. SRP54,
Hsp70, and Hsp90 were detected in the same
samples by immunoblotting. The distortion
of Sec61b in lanes 3 and 4 is comigrating
hemoglobin.
(B) Individual fractions from a gradient similar to
(A) were treated with BMH, a sulfhydryl reactive
crosslinker (XL). Fraction 5 in the absence of
crosslinker is shown for comparison. The major
crosslinking partner (p40), minor crosslinks
(arrowheads), and uncrosslinked Sec61b (*)
are indicated.
(C) Fractions 5 and 8 from a gradient as in (A)
were tested for insertion into RM and rRM.
Phosphorimaging showed 2.5-fold higher in-
sertion efficiency in fraction 5.
(D) Diagram of expectations for the fate of cyto-
solic Sec61b-containing complexes that are
(left) or are not (right) intermediates on the path-
way of membrane insertion.
(E and F) In-vitro-synthesized Sec61b was in-
cubated for 30 min at 32C with the indicated
vesicles, divided in two, and analyzed by either
crosslinking (E) or protease protection (F). Note
the disappearance of p40 crosslinks only in the
samples where insertion has occurred.analyses. We reasoned that during targeting, TA protein
substrates are likely to engage a targeting complex that,
at the very least, prevents exposure of the hydrophobic
TMD to the aqueous environment. Indeed, sucrose veloc-
ity gradient analyses (Figure 2A) of in-vitro-synthesized
Sec61b at a step prior to the addition of RMs showed it
to be in very heterogeneous complexes ranging from
4 S to 11 S (roughly100 to more than 500 kDa). Forma-
tion of these complexes was dependent on the TMD, but
was not influenced by the presence or placement of epi-
tope tags (Figure S2A and data not shown).
Analysis of each fraction by chemical crosslinking re-
vealed a variety of crosslinking partners, the most promi-
nent of which was an 40 kDa protein found largely in
fractions 4 through 7 (Figure 2B). These crosslinks were
observed with various concentrations of both lysine- and
cysteine-reactive crosslinkers, not seen with Sec61b lack-
ing the TMD, and not influenced by the choice or location
of epitope tags (Figures S2B and S2C). Importantly, the
peak fractions containing this crosslink were clearly sepa-
rated from peak fractions containing SRP (in which cross-
links to SRP54 were not detectable; Figure S2D). The in-
teraction with p40 was highly sensitive to detergent
(Figure S2E), but relatively stable in the presence of ele-
vated salt (to 250 mM; data not shown), suggesting pre-
dominantly hydrophobic-based interactions consistent
with involvement of the substrate’s TMD.
The peak p40-containing fraction displayed noticeably
higher efficiency of insertion when compared with the1150 Cell 128, 1147–1159, March 23, 2007 ª2007 Elsevier Inc.peak SRP-containing fraction (Figure 2C), suggesting
the possibility that the p40-Sec61b complex is an inser-
tion-competent intermediate. To test this idea, we per-
formed crosslinking analyses before and immediately
after incubation with membrane vesicles. We reasoned
that a bona fide intermediate complex would disassemble
concomitant with insertion, whereas off-pathway com-
plexes would be maintained as a noninserted population
(Figure 2D). Crosslinks between Sec61b and p40 dis-
appeared concomitant with membrane insertion into
either RM or rRM, but not after incubation with insertion-
incompetent liposomes (Figures 2E and 2F). Other cross-
links were observed to remain unchanged regardless of
membrane incubations (Figure S2F), suggesting that
these (relatively minor) interactions represent populations
of Sec61b that are not on the productive insertion path-
way. Based on the TMD-dependent interaction with
Sec61b at a step before (but not after) insertion, we hy-
pothesized that p40 may represent a component of a TA
protein-targeting machinery that we have termed TRC.
This 40 kDa component, which will be the focus of the re-
mainder of this study, will subsequently be called TRC40.
Identification and Characterization of TRC40
as a Component of TRC
To identify TRC40, we affinity-purified the in-vitro-gener-
ated Sec61b-TRC complex (Figure 3A) using anti-peptide
antibodies directed against the extreme N terminus of
Sec61b under conditions predetermined to preserve
Figure 3. TRC40 Is an ATPase Involved in
Posttranslational Membrane Protein
Targeting
(A) Sec61b and Sec61b(DTMD) were translated
in vitro and isolated by immunoaffinity purifica-
tion under native conditions. The top and bot-
tom panels show the Coomassie-stained gel
and autoradiograph, respectively, of samples
taken at each step in the purification.
(B) Sucrose velocity gradient analysis of immu-
noaffinity-purified Sec61b (from A) shows
a sedimentation profile similar to the starting
sample (compare to Figure 2A) and distinct
from constructs lacking the TMD (Figure S2A).
(C) Immunoaffinity-purified Sec61b and
Sec61b(DTMD) were analyzed by silver stain-
ing (left panel). Sample from a 20-fold larger
scale preparation of Sec61b was also analyzed
by Coomassie staining (right). The positions of
p40 and Sec61b (verified by mass spectrome-
try) are indicated.
(D) Sequence of TRC40. Tryptic peptides ob-
tained by mass spectrometry are underlined,
peptides used for raising antibodies are boxed,
the ATPase domain is in blue, and a conserved
hydrophobic patch in the C-terminal region is
green. (*) indicates the glycine mutated to
generate the ATPase-deficient mutant used in
Figure 6.
(E) Immunoblots for TRC40, SRP54, and Hsp70
of immunoaffinity-purified Sec61b and
Sec61b(DTMD) complexes prepared as in (A).
Different amounts of reticulocyte lysate (0.2 to
1 ml) were included on the same gel as the pu-
rified complexes derived from 5 ml and 30 ml of
translation reactions to estimate yield. An auto-
radiograph to confirm equal recovery of the
translation products is shown in the bottom
panel.
(F) Fractions from a sucrose gradient similar to
Figure 2A were probed with antibodies against
TRC40.
(G) The indicated mouse tissues were analyzed
by immunoblotting with antibodies against
TRC40.integrity of the complex. Upon peptide-elution under
physiologic conditions, the recovered material was con-
firmed by sucrose gradient analyses (Figure 3B) to still
be in similarly sized complexes as before, to display sim-
ilar crosslinking patterns (data not shown), and impor-
tantly, to insert into RM in an energy-stimulated manner
(data not shown; cf. Figure 1C). Comparison of the affin-
ity-purified complex to a parallel sample using Sec61b
lacking the TMD revealed a TMD-specific 40 kDa band
by silver staining (Figure 3C).
Large-scale translations were subjected to the same
procedure and the 40 kDa product (recovered in
a roughly 1:1 stoichiometry with Sec61b; Figure 3C) was
identified by mass spectrometry of the tryptic digests.
Seven independent peptide fragments matched the pre-
dicted sequence for a 348 amino acid protein that con-
tains a highly conserved N-terminal ATPase domain andCa C-terminal region containing a conserved hydrophobic
patch (Figure 3D; Figures S3A and S3B). This protein
was originally annotated Asna-1 in mammals due to
27% homology to a bacterial ATPase (ArsA) involved in
arsenite transport (Kurdi-Haidar et al., 1996). However,
these and subsequent authors have found little or no arse-
nite-stimulated ATPase activity (Kurdi-Haidar et al., 1998;
Mukhopadhyay et al., 2006), and conclude that the mam-
malian protein plays a different role than its distant bacte-
rial homolog. Although knockout of Asna-1 in mice results
in early embryonic lethality (Mukhopadhyay et al., 2006),
its function has remained unknown. Based on our func-
tional results below, we propose the name TRC40 for
this protein.
Two synthetic peptides from the predicted sequence of
TRC40 were used to raise antibodies that confirmed the
specific presence of TRC40 in the affinity-purifiedell 128, 1147–1159, March 23, 2007 ª2007 Elsevier Inc. 1151
Figure 4. Substrate Specificity of TRC40 for Posttranslational Membrane Protein Insertion
(A) In vitro translation reactions of Sec61b and Sec61b(DTMD) were treated with the sulfhydryl reactive crosslinker and immunoprecipitated under
denaturing conditions using the indicated antibodies. Anti-GFP served as a nonspecific antibody control. In other experiments, the preimmune
sera from the anti-TRC40 rabbits was used as a specificity control with identical results. The Sec61b(DTMD) autoradiograph is intentionally overex-
posed to illustrate complete lack of crosslinks to TRC40.
(B) Constructs encoding Sec61b or Cb5(69C)-3F4, each containing a single cysteine in a comparable position, were analyzed in parallel by cross-
linking and immunoprecipitation for interaction with TRC40. The weak crosslink between Cb5(69C)-3F4 and TRC40 could be observed only on longer
exposures (right).
(C) CFP-Sec61b and Sec61b-CFP were analyzed in parallel for crosslinking to TRC40. The double band is likely a consequence of crosslinks between
different residues.
(D) The indicated Nsyn1 constructs containing tails of various lengths from 3 to 154 residues were analyzed by crosslinking and immunoprecipitation
of TRC40. No systematic differences among these constructs in crosslinking efficiencies to TRC40 were observed.
(E) Reticulocyte lysate was separated into ribosomal and soluble (S-100) fractions that were analyzed by immunoblots for TRC40, SRP54, and Hsp70.
Ten-fold more ribosomes relative to S-100 were analyzed.
(F) Nsyn-108 was either synthesized completely (terminated) or made as a ribosome-nascent chain complex (RNC), both of which were analyzed by
crosslinking. Samples were either analyzed directly (‘‘total’’) or after immunoprecipitation for TRC40. The indicated samples were treated with RNase1152 Cell 128, 1147–1159, March 23, 2007 ª2007 Elsevier Inc.
Sec61b-TRC complex (Figure 3E). Of particular impor-
tance, TRC40 was not observed in parallel samples using
Sec61b lacking the TMD. Neither Hsp70 nor SRP54 were
found in appreciable quantities in the Sec61b-TRC com-
plex (Figure 3E and Figure S3C; see Supplemental Data).
Furthermore, both the N- and C-terminal anti-TRC40
antibodies could specifically immunoprecipitate the
Sec61b-TRC40 crosslink, while neither nonspecific anti-
bodies nor the preimmune sera was able to do so
(Figure 4A; data not shown). Finally, immunoblotting re-
vealed that TRC40 migrates in the position of the sucrose
gradient in which the 40 kDa crosslinks were most prom-
inently observed (Figure 3F; compare with Figure 2B).
Thus, the identified TRC40 protein is indeed the prominent
40 kDa crosslinking partner of TA proteins observed in
Figure 2.
As expected for a component of a general TA protein
targeting complex, TRC40 is highly conserved in all eu-
karyotes (Figure S3A; comparable to the level of Sec61a
conservation) and appears to be expressed universally
in all tissues and cultured cell lines examined so far
(Figure 3G). Our conservative estimate for the abundance
of TRC40 in reticulocyte lysate is at least20–50 nM, sev-
eral-fold higher than the estimated abundance of cytosolic
SRP (5–10 nM). Because the migration of TRC40 in the
sucrose gradient was unchanged in the presence or ab-
sence of Sec61b, its assembly into the larger TRC would
seem to not be induced by a TA substrate. This supposi-
tion was supported by specific crosslinks between
TRC40 and several other reticulocyte lysate proteins that
were maintained through various fractionation procedures
(Figures S3D and S3E). While the identification of the ad-
ditional component or components await complete purifi-
cation of native TRC, these results allow us to conclude
that TRC40 is one component of a larger preassembled
complex that interacts with Sec61b in a TMD-dependent
manner prior to its insertion into the ER membrane.
Selectivity of TRC40 Interactions with TA
Protein Substrates
Several TA and non-TA proteins were analyzed by cross-
linking and immunoprecipitation for their interaction with
TRC40 (summarized in Figure 4G). This analysis revealed
that deletion of the TMD from Sec61b completely abol-
ished any detectable interaction with TRC40 (Figure 4A),
while other TA proteins that are inserted by a nonsponta-
neous posttranslational pathway (Figure S4A) were readily
crosslinked to TRC40 (Figure S5 and data not shown). By
contrast, interaction of TRC40 with the spontaneously in-
serting Cb5 was markedly reduced relative to Sec61b
(Figure 4B). Importantly, no interactions could be detectedwith the cotranslational translocation substrates Prolactin
(Prl) or the prion protein (PrP) despite the fact that these
proteins contain hydrophobic domains (Figure S5). Both
contain an N-terminal signal sequence, and PrP addition-
ally contains an internal (potential) membrane spanning
domain and C-terminal hydrophobic domain used for gly-
cosylphosphatidylinositol (GPI) anchor addition. Thus,
even though Prl, PrP, and Cb5 are observed by sucrose
gradient analyses to be in high molecular weight com-
plexes in the cytosol (data not shown), these complexes
do not seem to include TRC40 as a principal interacting
component. This suggested that TRC40-substrate
interactions are more selective than simple hydrophobic-
ity, and pointed to a context-dependent TMD-mediated
interaction.
To test this idea directly, we examined TRC40 interac-
tions with Sec61b constructs appended with cyan fluores-
cent protein (CFP) at either the N or C terminus (termed
CFP-Sec61b and Sec61b-CFP, respectively). Although
both constructs are inserted into the ER membrane,
Sec61b-CFP is strictly cotranslational, while CFP-
Sec61b is inserted posttranslationally (Figure S4B). Re-
markably, TRC40 crosslinks were selectively observed
with CFP-Sec61b (Figure 4C), even though both con-
structs contain identical sequence elements, including
the TMD. Thus, TRC40 displays selectivity not only for cer-
tain TMDs, but also for the context in which these TMDs
are found.
However, the contextual cue or cues appear to be more
complex than simply a TMD at the C terminus. This be-
came evident when we analyzed a member of the syntaxin
family (most of which are TA proteins) from Neurospora
crassa (Nsyn1) that had evolved an unusually long 154 res-
idue C-terminal tail (Gupta et al., 2003). Nsyn1 constructs
containing tails ranging from 3 to 154 residues (termed
Nsyn-3 through Nsyn-154) all showed essentially identical
crosslinking efficiency to TRC40 (Figure 4D). While this
would seem to be at odds with the Sec61b-CFP result
above, it could be explained by our observation that
Nsyn-108 and Nsyn-154 are capable of posttranslational
insertion despite their unusually long tails (Figure S4C).
When considered together, these findings reveal a striking
relationship between a substrate’s interaction with TRC40
and its ability to be integrated into the ER by the nonspon-
taneous posttranslational membrane protein insertion
pathway. We therefore suggest that TRC40 has a con-
text-dependent specificity for TMDs in membrane pro-
teins that utilize this posttranslational pathway of insertion.
While this pathway is most widely used by TA proteins that
cannot access the cotranslational insertion pathway, it
seems that at least some substrates that ordinarily wouldimmediately prior to SDS-PAGE to remove any attached tRNA. The peptidyl-tRNA in the RNC sample verified that Nsyn-108 was ribosome associ-
ated at the time of crosslinking.
(G) Summary of all TRC40 crosslinking analyses and functional properties of various constructs. Schematic representations of constructs are shown
and aligned by their relative TMD position. Spontaneous insertion is defined as the ability to insert into liposomes (e.g., Cb5 in Figure 1D). DN inhibition
refers to the ability of a TRC40 dominant-negative protein to inhibit insertion (see Figure 6). n/a indicates not applicable (e.g., TA proteins cannot insert
cotranslationally and an RNC cannot be tested posttranslationlly), and nd indicates not done.Cell 128, 1147–1159, March 23, 2007 ª2007 Elsevier Inc. 1153
Figure 5. TRC40 Associates Peripherally
with the ER Membrane
(A) RM (lane 1) was diluted into hypotonic or hy-
pertonic buffer and recovered by sedimenta-
tion. Equal portions of the supernatants and
membrane pellets were analyzed by immuno-
blotting for the indicated products. The dilution
buffer contained 250 mM sucrose, 50 mM
HEPES (pH 7.4), and 0, 200, 400, or 600 mM
KAc as indicated. SRP is a known peripheral
protein removed by high salt, while Sec61b
serves as an integral membrane protein
control.
(B) Microsomes and cytosol from bovine liver
were analyzed by Coomassie staining (top) or
immunoblotting (bottom).
(C) Liver microsomes were incubated for
10 min under physiologic conditions (100 mM
KAc, 50 mM HEPES [pH 7.4], 2 mM MgAc2)
at the indicated temperatures in the presence
or absence of 1 mM ATP before separation
into soluble and membrane fractions and anal-
ysis by immunoblotting.use the SRP pathway (e.g., Nsyn1, which is not formally
a TA protein) can also take advantage of the TRC pathway
under some circumstances.
Hierarchical Interactions of Membrane Proteins
with SRP and TRC40
The ability of TRC40 to interact with a substrate (Nsyn1)
containing an internal TMD raised the issue of precisely
when and where TRC40 first engages substrate relative
to the other principal TMD recognition factor, SRP. Since
the TMD of Nsyn1 would emerge from the ribosome long
before reaching its termination codon, it is feasible in this
instance for TRC40 to bind the nascent (i.e., ribosome-
associated) polypeptide. Even for a C-terminal TMD, bind-
ing might occur as it emerges from the ribosomal exit
tunnel (e.g., if TRC were positioned there) to prevent expo-
sure of the TMD to the aqueous cytosolic environment.
To examine these ideas, we first examined the localiza-
tion of TRC40 in reticulocyte lysate. Unlike either SRP or
Hsp70 (both of which are known nascent chain binding
proteins; Krieg et al., 1986; Frydman et al., 1994), TRC40
was not found in association with ribosomes to any appre-
ciable degree (Figure 4E). This raised the possibility that
interaction of TRC40 with substrates occurs only upon
complete release from the ribosome into the cytosol. In-
deed, Nsyn-108 was found in a complex with TRC40 after
termination of translation, but not while it was a nascent
peptidyl-tRNA bound to ribosomes (at which step other
crosslinks were seen; Figure 4F). This result indicates
that when hydrophobic domains such as TMDs first
emerge from the ribosome, they are likely to be preferen-
tial substrates for SRP. This is because the signal recogni-
tion cleft of SRP is poised at the ribosomal exit tunnel, ef-
fectively creating a very high local concentration (Halic
et al., 2004). Upon release from the ribosome, however,1154 Cell 128, 1147–1159, March 23, 2007 ª2007 Elsevier Inc.a suitably positioned TMD (i.e., in the context of a TA
protein) is now a far better substrate for interaction with
TRC. This is probably a combination of both a higher
free cytosolic concentration of TRC relative to SRP and
possibly a higher affinity of interaction in the nonribosomal
context. We conclude from the above analyses that upon
release of a TMD-containing protein from the ribosome, it
is preferentially recognized by TRC, while ribosome-
associated nascent chains containing TMDs are preferen-
tially recognized by SRP. Thus, these two complexes,
which can recognize TMDs, do not interfere or compete
with each other for substrate.
Reversible Binding of TRC40 to the ER Membrane
A key role for a putative targeting factor such as TRC
would be its regulated binding and release from mem-
branes competent for insertion of TA proteins. Indeed, im-
munoblots revealed that RMs contain substantial
amounts of peripherally associated TRC40 that can be ex-
tracted by low salt, high pH (11.5), urea (2M), or small
amounts of detergent (Figure 5A and data not shown).
Fractionation of liver under physiologic conditions sug-
gested that at steady state, 30%–60% of TRC40 is
bound to membranes (Figure 5B). Notably, a significant
amount of this membrane-bound population of TRC40
could be released from the membrane under physiologic
conditions upon brief (10 min) incubation with ATP
(Figure 5B). This raised the possibility that the ATPase
activity of TRC40 might play a role in the putative TRC tar-
geting cycle. Thus, in addition to being free in the cytosol,
endogenous TRC40 can also be found in a membrane-
bound form that may represent association with a mem-
brane-localized receptor. Consistent with this idea,
in-vitro-synthesized TRC40 was observed to bind ER
membranes, but not liposomes (data not shown).
ATPase-Dependent Transfer of TA Proteins from
TRC40 to the ER Membrane
The transient interaction of TRC40 with both TA proteins
and a putative ER-localized receptor pointed to a possible
targeting function in which TRC delivers its substrates for
subsequent membrane insertion. Attempts to demon-
strate this proposed functional role by immunodepletion
of TRC40 were hindered because neither of our anti-
TRC40 antibodies recognized the native protein. We
therefore took another approach. The energy dependence
of TA protein insertion (Kutay et al., 1995; Figure 1C), to-
gether with the observations that TRC40 is an ATPase
whose membrane binding is influenced by ATP (Fig-
ure 5C), suggested to us a model in which ATP hydrolysis
coordinates the targeting step (analogous to the use of
GTPases in the SRP-dependent targeting pathway). We
therefore reasoned that if TRC40 indeed plays a direct
role in targeting, an ATPase-deficient mutant may act to
dominantly and selectively inhibit TA protein insertion.
A glycine to arginine point mutant in the highly con-
served ATP binding pocket of TRC40 (shown previously
to disrupt ATPase activity; Shen et al., 2003) was recom-
binantly expressed, purified, and added at submicromolar
concentrations to various translocation reactions. While
this mutant (termed TRC40-DN, for dominant-negative)
had no effect on cotranslational translocation of Prl
(Figure 6A), it dose-dependently inhibited the posttransla-
tional insertion of Sec61b and other TA proteins
(Figure 6A). When added to posttranslational translocation
reactions of signal sequence-containing a-factor across
yeast microsomes (Figure 6B), TRC40-DN had no effect
(except a slight nonspecific effect on translation at the
highest concentrations). Furthermore, TRC40-DN had
only a modest effect on the spontaneously inserting Cb5
substrate (Figure 6C). Considered together, these results
indicate that the ATPase-deficient TRC40 dominantly in-
hibits the principal TA protein insertion pathway without
substantial effects on the known cotranslational (Gorlich
and Rapoport, 1993), posttranslational (Panzner et al.,
1995), or spontaneous (Brambillasca et al., 2005) translo-
cation pathways. These functional effects correlated well
with the crosslinking results (Figure 4G): those substrates
that interact with TRC40 are inhibited by the ATPase mu-
tant, while substrates like Prl that do not interact with
TRC40 are not inhibited. The partial effect on Cb5 is again
consistent with its apparently weak interaction with
TRC40 (Figure 4B) and its access to the alternate sponta-
neous insertion pathway (Brambillasca et al., 2005).
The high level of TRC40 selectively for only the post-
translational membrane insertion pathway was analyzed
in another way by examining Nsyn-108, a substrate that
is normally inserted cotranslationally, but is also capable
of posttranslational insertion after ribosome release
(Figure S4C). Addition of TRC40-DN to cotranslational
translocation reactions of Nsyn-108 had little effect on
its membrane integration (Figure 6D). By striking contrast,
insertion of this same substrate into the same membranes
was inhibited potently by TRC40-DN if the reaction wasCperformed posttranslationally. This result argues strongly
for the existence of distinct parallel membrane insertion
pathways that utilize different subsets of components,
among which TRC40 is selectively posttranslational. Iden-
tical results were obtained with Nsyn-154 (data not
shown).
Based on these findings, we surmised that the mecha-
nism of dominant inhibition was direct binding of
TRC40-DN to ribosomally released substrate. Due to de-
ficient ATPase activity, TRC40-DN would prevent sub-
strate targeting to or release at the ER membrane. To
test this, we analyzed the interactions between Sec61b
and endogenous TRC40 versus exogenously added (and
epitope-tagged) TRC40-DN. At a level of TRC40-DN that
inhibits TA insertion by 50%, crosslinks to the endoge-
nous and exogenous proteins were roughly equal (Figures
6E and 6F). Higher levels of TRC40-DN resulted in in-
creased crosslinking (at the expense of endogenous
TRC40 crosslinks) that correlated with increased inhibition
of Sec61b (Figure 6F). Upon addition of insertion-compe-
tent microsomes, Sec61b was released more efficiently
from endogenous TRC40 than from exogenous TRC40-
DN (Figure 6G). The unreleased TRC40-DN-substrate
complex was found by sedimentation assays to be at least
partially membrane bound (data not shown), suggesting
that targeting may be normal, but ATPase-dependent re-
lease and subsequent insertion were blocked. Considered
together, these findings suggest that TRC40 interacts di-
rectly with substrate, after which it delivers the TA protein
to the membrane where its ATPase activity is necessary
for substrate release, subsequent insertion, and recycling
of TRC for another round of targeting.
A Working Model for TA Protein Insertion
The results in this study have led to the identification of the
first component of a poorly characterized but widely used
posttranslational pathway of membrane protein insertion.
Our subsequent mechanistic analyses of TRC40 delineate
a working framework for the principal steps in this target-
ing and insertion pathway (Figure 7) and identify specific,
important directions for future studies.
Based on the sedimentation (Figure 3F), crosslinking
(Figure S3D), and fractionation (Figure S3E) analyses,
TRC40 appears to be preassembled into the larger cyto-
solic TRC even in the absence of substrate. While this
complex can be membrane bound (Figure 5), at least
half of TRC appears to be free in the cytosol, awaiting ribo-
some-released TMD-containing substrates. This places
TRC ‘‘second in line’’ behind SRP for TMD interaction.
The affinity of SRP for ribosomes (Ogg and Walter, 1995)
and its positioning relative to the ribosomal exit tunnel
(Halic et al., 2004) provides a competitive advantage for
nascent chain interactions. This advantage is lost upon
translational termination, since TMD-containing polypep-
tides released into the cytosol appear to be preferentially
bound to non-SRP-containing complexes (Figure 2B and
Figures S2C and S2D), the principal one of which is TRC
(whose abundance also appears to be greater thanell 128, 1147–1159, March 23, 2007 ª2007 Elsevier Inc. 1155
Figure 6. An ATPase Mutant of TRC40
Selectively Inhibits TAMembrane Protein
Insertion
(A–C) The indicated proteins were synthesized
in the presence of increasing concentrations
(from 0 to 0.5 mM) of recombinant TRC40-DN
(containing a glycine to arginine mutation at po-
sition 46 in the Walker A box) and analyzed for
translocation by the protease protection assay.
For Prl translocation, RMs were included dur-
ing the translation reactions, while the other
translocation reactions were performed post-
translationally. Graphs to the right of each rep-
resentative experiment show the average of
between two and five independent replicates.
Yeast RMs were used in (B).
(D) Nsyn-108 was translated in the presence of
increasing concentrations of recombinant
TRC40-DN, analyzed for translocation by the
protease protection assay, and quantified by
phosphorimaging. In one set of reactions,
RMs were included during translation to permit
cotranslational translocation (open symbols),
while the other reactions were performed post-
translationally using fully synthesized, ribo-
some-released Nsyn-108 (closed symbols).
(E) Sec61b translated in the absence (top) or
presence (bottom) of 0.2 mM TRC40-DN was
analyzed by crosslinking and immunoprecipi-
tation with antibodies against Sec61b,
TRC40, the tag on TRC40-DN, or an irrelevant
antibody (NIS). The slower migration of
TRC40-DN crosslinks relative to endogenous
TRC40 is due to the epitope tag, and the dif-
fuseness of this band is caused by comigrating
IgG heavy chain.
(F) Sec61b translated in the presence of the in-
dicated concentration of TRC40-DN was sub-
jected to crosslinking and immunoprecipitation
with anti-TRC40. The relative crosslinking to
exogenous TRC40-DN (as a percent of total
TRC40 crosslinks) is indicated below the gel,
as are the relative insertion efficiencies at the
respective TRC40-DN concentrations.
(G) Crosslinking analysis of Sec61b translated
in the presence of 0.5 mM TRC40-DN before
and after incubation with RM. The percent of
total TRC40 crosslinks remaining after RM in-
cubation was quantified by phosphorimaging
and is indicated below the gel. Note that
release from TRC40-DN is relatively poor
upon incubation with RM when compared
with release from endogenous TRC40.SRP’s in reticulocyte lysate). How TRC out-competes
chaperones such as Hsp70 remains unclear. One possibil-
ity is that while Hsp70 binds and releases from substrates
in an ATPase-driven cycle (Mayer and Bukau, 2005), the
TRC40-substrate interaction is stable until its delivery to
the membrane (e.g., Figure S2E). Thus, we favor a model
in which TRC acts as a ‘‘trap’’ to sequester cytosolic TMD-
containing substrates from other potential interacting
partners that may serve to temporarily prevent substrate
aggregation.1156 Cell 128, 1147–1159, March 23, 2007 ª2007 Elsevier Inc.The mechanism underlying the specificity of TRC for
TMDs remains to be determined. However, two points
are worth noting. First, simple hydrophobicity is not likely
to be the sole determinant since substrates containing
a signal sequence, C-terminal GPI-anchoring signal, or
a spontaneously inserting TMD were all poor substrates
for TRC interaction, and were also not significantly in-
hibited by TRC40-DN (Figure 4G). Second, the interaction
of TRC is not limited solely to TMDs at the extreme C ter-
minus (Figure 4D). Thus, the TRC-dependent pathway
Figure 7. Model for the Role of TRC40 in
Posttranslational Membrane Protein
Insertion
The cotranslational SRP pathway (left) is com-
pared with the posttranslational pathway (right)
mediated by the multicomponent TRC (whose
ATPase TRC40 subunit is shown in red). The
basic steps of substrate synthesis (1), recogni-
tion of the TMD (2), receptor-mediated target-
ing to the ER membrane (3), and nucleotide
hydrolysis-dependent substrate release (4)
are indicated in each pathway. The posttarget-
ing step of TMD insertion is not depicted. The
two pathways do not interfere or compete
with each other due to the distinct mechanisms
of SPR versus TRC function (see text for
details). Thus, the substrate clienteles (and membrane-bound machinery) for the TRC- and SRP-dependent pathways are proposed to be distinct.
Only certain unusual TA proteins with long tails would be capable of using both systems.may be utilized by not only TA proteins, but also mem-
brane proteins that, for one reason or another, missed
their opportunity to target via the SRP-dependent path-
way. Of course, the TRC pathway presumably has many
additional constraints and would fail to insert complex
membrane proteins or those whose intended lumenal
domains had already folded (such as Sec61b-CFP;
Figure 4C). But our demonstration that Nsyn1, with a tail
of 154 residues, can not only interact with TRC40
(Figure 4D) but also be inserted posttranslationally
(Figure S4C) provides one example of a membrane pro-
tein that can insert by both co- and posttranslational path-
ways that utilize different machineries and operate in
parallel.
Once bound to a TMD-containing substrate in the cyto-
sol, TRC presumably interacts with a putative receptor at
the ER membrane. This interaction does not appear to
be dependent on engaging a substrate since in-vitro-
synthesized TRC40 can bind ER microsomes (data not
shown). Furthermore, native ER microsomes contain pre-
bound TRC40. Binding of substrate to TRC may enhance
its interaction with the membrane receptor, but this needs
to be further explored. An analogy to the SRP targeting
system is applicable here: while SRP has an affinity for
both empty ribosomes and its ER-bound receptor, the
presence of a nascent chain substrate (and nucleotide)
substantially enhances these interactions to favor efficient
targeting without substantial competition by free SRP. We
envisage an analogous situation for TRC (Figure 7).
Release of substrate from TRC at the membrane is de-
pendent on the ATPase activity of TRC40. At least three
reactions must occur at this step. First, the ATPase activity
of TRC40 is presumably stimulated by its receptor interac-
tion. Second, substrate must be released from TRC40
upon ATP hydrolysis. Third, the released TMD must then
either be inserted directly into the membrane or trans-
ferred to an ‘‘insertase’’ that mediates membrane integra-
tion of the TMD and translocation of the tail. It seems
unlikely that insertion is ‘‘spontaneous’’ upon release
from TRC40 given that even large regions of up to 154 res-
idues can be translocated simultaneously with insertion.CThe simplest model is that the putative receptor
for TRC40 carries out all three activities by stimulating
the TRC40 ATPase, binding to the substrate released
from TRC40, and serving as the insertase.
Recently, the homolog of TRC40 in S. cerevisiae
(termed Arr4 or Get3) has been implicated in a variety of
processes, including Golgi-to-ER trafficking, ER-associ-
ated degradation, sporulation, regulation of ion transport,
and tolerance to certain stresses (Shen et al., 2003;
Schuldiner et al., 2005; Metz et al., 2006; Auld et al.,
2006). The relationship between these phenotypes in
yeast and our demonstrated role of mammalian TRC40
in TA protein insertion remains unclear at present. One ex-
planation is that Arr4/Get3 has a functional role or roles in
yeast that are distinct from and unrelated to the TA inser-
tion pathway. Alternatively, the conclusion by Auld et al.
(2006) that all of these phenotypes are connected in
some way to intracellular membrane composition and or-
ganization raises the possibility that partial defects in TA
protein insertion might underlie some or all of these pleio-
tropic effects. If this were the case, one would have to
postulate that another insertion pathway or pathways
can compensate to a large degree in yeast (since Arr4/
Get3 deletion is not lethal), but not in mammals, where dis-
ruption of TRC40 shows early embryonic lethality (Mukho-
padhyay et al., 2006). Development of quantitative assays
for TA protein insertion of multiple substrates in the yeast
system will be needed to investigate these questions in
depth and determine the extent to which the machinery
of this translocation pathway is conserved across diverse
species.
Toward this end, it is clear that identification of the com-
plete TRC, as well as the membrane component or com-
ponents that serve as the putative TRC receptor, repre-
sent important future goals. Our discovery of TRC40 as
a central ATPase that coordinates the targeting and mem-
brane insertion reactions should now greatly facilitate the
purification of other pathway components. Once these are
in hand, the process of posttranslational membrane
protein insertion can be reconstituted with purified
components to fully dissect its mechanistic basis.ell 128, 1147–1159, March 23, 2007 ª2007 Elsevier Inc. 1157
EXPERIMENTAL PROCEDURES
Materials
All constructs used in this study were made by standard methods and
verified by sequencing. The initial cDNA for human TRC40 was ob-
tained from Origene, and Nsyn1 from G. Gupta and B. Heath (Gupta
et al., 2003). A complete list of constructs and their composition is pro-
vided in Table S1. Rabbit antisera to the N- and C-terminal regions of
TRC40 and to the 3F4 epitope were generated by immunizing rabbits
with KLH-conjugated synthetic peptides (see Figure 3D and
Figure S1A). Antibodies to GFP were raised against recombinant
His-tagged GFP (from G. Patterson) expressed from the pRSETA vec-
tor in E. coli. This antiserum recognizes both the epitope tag and GFP,
and was used for either purpose as indicated in the figure legends.
Yeast RMs were a gift from T. Rapoport. Bovine liver microsomes
and cytosol were prepared by differential centrifugation as for pancre-
atic RMs (Walter and Blobel, 1983), except homogenization and frac-
tionation was performed in physiologic salt buffer (100 mM KAc,
50 mM HEPES [pH 7.4], 2 mM MgAc2, 250 mM sucrose), and the su-
crose cushion for the final centrifugation step was 0.8 M instead of
1.3 M. The sources of published or commercially available materials
used in this study are provided in the Supplemental Data.
Insertion and Translocation Assays
Assays for cotranslational translocation (of Prl, PrP, GFP-fusions, and
Nsyn1 constructs), posttranslational insertion (of Sec61b, Cb5, and
various other TA-proteins), and posttranslational translocation (of
a-factor and other proteins) have been described (Fons et al., 2003;
Brambillasca et al., 2005; Panzner et al., 1995). In general, co- and
posttranslational reactions were for 30 min at 32C. Unless otherwise
indicated, an energy regenerating system (1 mM ATP, 1 mM GTP,
10 mM Creatine phosphate, and 40 mg/ml creatine kinase) was present
during the incubation. Posttranslational reactions were generally per-
formed on samples treated with a protein synthesis inhibitor, depleted
of ribosomes by centrifugation (70,000 rpms for 30 min in a TL100.3 ro-
tor), or both. Any modifications to these methods are indicated in the
figure legends, with additional details provided in the Supplemental
Data.
Sucrose Gradient Analyses
Gradients were 5%–25% (w/v) sucrose in physiological salt buffer
(PSB; 100 mM KAc, 50 mM HEPES [pH 7.4], 2 mM MgAc2). Sedimen-
tation was for 5 hr at 55,000 rpm in a TLS-55 rotor (Beckman) at 4C.
RNCs were isolated using 10%–50% (w/v) sucrose gradients in PSB
spun for 1 hr at 55,000 rpms. Either 10 or 11 fractions were manually
collected from the gradients and analyzed directly or subjected to
further manipulations (such as crosslinking and insertion assays as
described in individual figure legends).
Crosslinking Analyses
Samples for crosslinking (generally taken from the appropriate fraction
or fractions of a sucrose gradient) were adjusted to between 20 and
500 mM BMH or DSS (as indicated in the figure legends) added from
freshly prepared stocks in DMSO (whose final concentration in the
reaction did not exceed 2%). BMH reactions were incubated on ice
for 30 min, while DSS was reacted at room temperature for 30 min. Re-
actions were quenched with 100 mM 2-mercaptoethanol, 100 mM
Tris, or both before either direct analysis or further processing (e.g.,
for immunoprecipitation).
Immunoaffinity Isolation and Identification of TRC40
A 0.2 to 0.5 ml column of anti-Sec61b (against the extreme N terminus)
immobilized on Protein A agarose was washed briefly in 0.2 M glycine
(pH 2.3) and equilibrated in PSB at 4C. Translation reactions [either
1 ml (small scale) or 20 ml (large scale)] were depleted of ribosomes
by centrifugation and passed over the resin (sometimes up to three
times) at 4C. The column was washed extensively with PSB, and in1158 Cell 128, 1147–1159, March 23, 2007 ª2007 Elsevier Incsome cases, with PSB containing 250 mM KAc. Elution was with
1 mM peptide for 30 min at room temperature in PSB. For subsequent
sucrose gradients, insertion analyses, or immunoblots, samples were
used directly. For analysis by staining or high-sensitivity immunoblots,
proteins were concentrated by precipitation with TCA in the presence
of 0.5% Triton X-100 carrier, washed in acetone, and dissolved in 1%
SDS. Bands were excised from Coomassie-stained gels for tryptic di-
gests and mass spectrometry (performed by Midwest Bio Services).
Recombinant Expression and Purification
Expression in E. coli from the pRSETA vector was induced with IPTG,
and the His-tagged protein (which was largely insoluble) was purified
under denaturing conditions (with 4M urea) using immobilized Ni+2
(on chelating sepharose from Amersham). The protein was refolded
on the column by washing extensively with PSB and eluted with imid-
azole in PSB before dialysis against PSB to remove imidazole.
Miscellaneous Methods
Immunoprecipitations in this study were always under denaturing
conditions. After samples were heated in 1% SDS to 100C, they
were diluted 10-fold in IP buffer (1% Triton X-100, 50 mM HEPES
[pH 7.4], 100 mM NaCl) at 4C and immunoprecipitated as before
(Fons et al., 2003). Most analyses were on 12% Tris-Tricine gels con-
taining 0.1% SDS. Some analyses (Figure 3C, Figures S2C, S2D, and
S3D) used 10% Tris-Glycine gels. Immunoblotting utilized nitrocellu-
lose. Optimal antibody dilutions were determined empirically in prelim-
inary experiments. Secondary antibodies were HRP-conjugated.
Development was with chemiluminescence reagents from Pierce.
Quantification of radiolabeled gels employed the Typhoon phosphor-
imager system with accompanying software. Figures were made
from scanned films using Adobe Photoshop and Illustrator software.
Supplemental Data
The Supplemental Data for this article can be found online at http://
www.cell.com/cgi/content/full/128/6/1147/DC1/.
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